Kymera Therapeutics (KYMR) PT Raised to $68 at Truist Securities
Tweet Send to a Friend
(Updated - September 30, 2025 8:08 AM EDT)
Truist Securities analyst Srikripa Devarakonda raised the price target on Kymera ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Truist Securities analyst Srikripa Devarakonda raised the price target on Kymera ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
